IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 7 holdings | $388.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Springworks Therapeutics IncCOM85205L107$157.9K7,281,30740.6%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$105.3K7,330,23727.1%
Solid Biosciences IncCOM83422E105$40.0K3,871,16410.3%
Replimune Group Inc(REPL)COM76029N106$39.5K2,838,96810.2%
Dynavax Technologies Corp(DVAX)COM268158201$30.3K8,452,2357.8%
Marinus Pharmaceuticals IncCOM56854Q101$7.8K5,042,7352.0%
Aptinyx IncCOM03836N103$7.8K2,225,0922.0%